Evolution of H5N1 Avian Influenza Viruses in Asia

Human infections were from a virus clade undergoing antigenic drift that showed resistance to adamantanes but sensitivity to neuraminidase inhibitors.

Keiji Fukuda | David E. Swayne | Nguyen Tien Dung | Guohua Deng | Takehiko Saito | Philippe Buchy | Amanda Balish | Timothy M. Uyeki | Michael Shaw | Ruben O. Donis | Xiyan Xu | Takato Odagiri | Masato Tashiro | Sylvie van der Werf | Chun Kang | Haan Woo Sung | Rebecca Garten | Jean Thierry Aubin | Nguyen Thi Hong Hanh | R. Webster | R. Webby | M. Peiris | S. Dowell | N. Cox | K. Fukuda | M. Shaw | R. Garten | Xiyan Xu | T. Uyeki | A. Curns | E. Govorkova | E. Hoffmann | Y. Matsuoka | I. Brown | G. Deng | Yanbing Li | T. Tumpey | N. Bhat | P. Buchy | S. Vong | M. Imai | D. Suarez | M. Tashiro | A. Douglas | A. Hay | J. Manuguerra | R. Donis | A. Klimov | J. Katz | T. Maines | R. Bright | Chang-won Lee | V. Gregory | C. Kang | Y. Lin | T. Odagiri | W. Lim | M. Perdue | D. Swayne | S. Itamura | S. Desvaux | M. Mase | S. Werf | J. Banks | N. H. Hạnh | J. Aubin | M. Tardy-Panit | L. Mai | A. Balish | A. Burguière | Takehiko Saito | S. Sangkitporn | K. Stöhr | Robert G. Webster | Erich Hoffmann | Nancy J. Cox | Wilina Lim | Erica Spackman | Michael L. Perdue | David L. Suarez | Terrence M. Tumpey | Richard J. Webby | P. Thawatsupha | J. Simmerman | P. Jeannin | Alan Hay | Alexander Klimov | Victoria Gregory | P. Lien | J. Reynes | A. Hampson | M. Obuchi | James Mark Simmerman | Elena A. Govorkova | Julia A Desheva | Malik Peiris | N. Dung | Niranjan Bhat | Sirenda Vong | S. Harper | M. Medina | Diane Hulse | Yi Pu Lin | Scott F. Dowell | Masaji Mase | Rick A. Bright | E. Spackman | Yong-kuk Kwon | A. Ninomiya | Masaki Imai | Aaron Curns | Taronna R. Maines | Claudine Rousseaux | Chang-Won Lee | D. Hulse | Ai Ninomiya | Ian H. Brown | Alan W. Hampson | Masatsugu Obuchi | Doan C. Nguyen | Samadhan Jadhao | Jill Banks | Klaus Stöhr | A. R. Douglas | Pranee Thawatsupha | Margaret McCarron | Saliha Azebi | Ana Maria Burguiere | Hua Ian Chen | Peter K.C. Cheng | Alice Crosier | Frédérique Cuvelier | Julia Desheva | Stéphanie Desvaux | Nguyen Hong Diep | Lindsay E. Edwards | Scott A. Harper | Shigeyuki Itamura | Patricia Jeannin | Jackie Katz | Jae Hong Kim | Yong Kuk Kwon | Phuong Song Lien | Yanbing Li | Stephen Lindstom | La Morris Loftin | Jan Mabry | Le Quynh Mai | Jean Claude Manuguerra | Yumi Matsuoka | Marie-Jo Medina | Doan Nguyen | Jean Marc Reynes | James Robertson | Somchai Sangkitporn | M. Slomka | Catherine K. Smith | San Sorn | Maryse Tardy-Panit | Phan Van Tu | John Wood | Guan Yi | Wenging Zhang | Frédérique Cuvelier | J. Desheva | M. Slomka | S. Sorn | D. Nguyen | H. Sung | N. H. Diep | Saliha Azébi | P. Cheng | P. V. Tú | J. Mabry | S. Jadhao | M. McCarron | Catherine Smith | C. Rousseaux | H. Chen | A. Crosier | Stephen Lindstom | L. Loftin | J. Robertson | John Wood | G. Yi | Wen-gui Zhang | N. H. Hanh | Y. P. Lin | Y. Kwon | Niranjan Bhat | Phan Văn Tú | J. Katz | Takehiko Saito

[1]  A. Amonsin,et al.  Probable Tiger-to-Tiger Transmission of Avian Influenza H5N1 , 2005, Emerging infectious diseases.

[2]  J. Wood,et al.  Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. , 2005, Vaccine.

[3]  M. Kiso,et al.  Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. , 2005, Virology.

[4]  Prasert Auewarakul,et al.  Probable person-to-person transmission of avian influenza A (H5N1). , 2005, The New England journal of medicine.

[5]  Yong Poovorawan,et al.  Avian Influenza H5N1 in Tigers and Leopards , 2004, Emerging infectious diseases.

[6]  Thijs Kuiken,et al.  Avian H5N1 Influenza in Cats , 2004, Science.

[7]  Y. Guan,et al.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia , 2004, Nature.

[8]  Xiyan Xu,et al.  Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons. , 2004, Virus research.

[9]  R. Webster,et al.  H5N1 influenza: a protean pandemic threat. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Y. Guan,et al.  Reemerging H5N1 Influenza Viruses in Hong Kong in 2002 Are Highly Pathogenic to Ducks , 2004, Journal of Virology.

[11]  Y. Guan,et al.  Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines , 2004, The Lancet.

[12]  Andrew C. R. Martin,et al.  Restrictions to the Adaptation of Influenza A Virus H5 Hemagglutinin to the Human Host , 2004, Journal of Virology.

[13]  R. Pearl.  Outbreaks of avian influenza A (H5N1) in Asia and interim recommendations for evaluation and reporting of suspected cases--United States, 2004. , 2004, MMWR. Morbidity and mortality weekly report.

[14]  K G Nicholson,et al.  Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin , 2003, Journal of medical virology.

[15]  N. Cox,et al.  Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. , 2003, Virology.

[16]  Production of pilot lots of inactivated influenza vaccine in response to a pandemic threat: an interim biosafety risk assessment. , 2003, Releve epidemiologique hebdomadaire.

[17]  Evaluation of a High-Pathogenicity H5N1 Avian Influenza A Virus Isolated from Duck Meat , 2003, Avian diseases.

[18]  R. Webster,et al.  Eight-plasmid system for rapid generation of influenza virus vaccines. , 2002, Vaccine.

[19]  G. M. Cross.  Hemagglutination inhibition assays , 2002 .

[20]  A. García-Sastre,et al.  Plasmid-only rescue of influenza A virus vaccine candidates. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[21]  S. Baigent,et al.  Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture. , 2001, Virus research.

[22]  J. Skehel,et al.  X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Oxford,et al.  Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. , 2001, JAMA.

[24]  R. Webster,et al.  Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus from eight plasmids. , 2000, The Journal of general virology.

[25]  R. Webster,et al.  The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. , 2000, Antiviral research.

[26]  L. Mitnaul,et al.  Balanced Hemagglutinin and Neuraminidase Activities Are Critical for Efficient Replication of Influenza A Virus , 2000, Journal of Virology.

[27]  R. Webster,et al.  A DNA transfection system for generation of influenza A virus from eight plasmids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Suarez,et al.  Structural features of the avian influenza virus hemagglutinin that influence virulence. , 2000, Veterinary microbiology.

[29]  A. García-Sastre,et al.  Rescue of influenza A virus from recombinant DNA. , 2007, Journal of virology.

[30]  Tokiko Watanabe,et al.  Generation of influenza A viruses entirely from cloned cDNAs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  N. Cox,et al.  Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. , 1999, Virology.

[32]  R. Webster,et al.  The Surface Glycoproteins of H5 Influenza Viruses Isolated from Humans, Chickens, and Wild Aquatic Birds Have Distinguishable Properties , 1999, Journal of Virology.

[33]  K. Subbarao,et al.  Influenza vaccines: present and future. , 1999, Advances in virus research.

[34]  I. Wilson,et al.  Structural basis of immune recognition of influenza virus hemagglutinin. , 1990, Annual review of immunology.

[35]  J. Skehel,et al.  The molecular basis of the specific anti‐influenza action of amantadine. , 1985, The EMBO journal.

[36]  J. Devereux,et al.  A comprehensive set of sequence analysis programs for the VAX , 1984, Nucleic Acids Res..

[37]  E. D. Kilbourne.  Future influenza vaccines and the use of genetic recombinants. , 1969, Bulletin of the World Health Organization.